These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 22111333

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Current treatment of multiple sclerosis].
    Csépány T.
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [Abstract] [Full Text] [Related]

  • 4. [New therapies in multiple sclerosis].
    Roggerone S, Chenevier F, Confavreux C, Vukusic S.
    Rev Prat; 2012 Oct; 62(8):1057-60. PubMed ID: 23227596
    [Abstract] [Full Text] [Related]

  • 5. [Update on current care guidelines: multiple sclerosis].
    Duodecim; 2013 Oct; 129(5):548-9. PubMed ID: 23520898
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New management algorithms in multiple sclerosis.
    Sorensen PS.
    Curr Opin Neurol; 2014 Jun; 27(3):246-59. PubMed ID: 24759080
    [Abstract] [Full Text] [Related]

  • 10. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 11. Current disease-modifying treatment of multiple sclerosis.
    Derwenskus J.
    Mt Sinai J Med; 2011 Jun; 78(2):161-75. PubMed ID: 21425262
    [Abstract] [Full Text] [Related]

  • 12. Emerging disease-modifying oral therapies for multiple sclerosis.
    Losy J, Kalinowska-Łyszczarz A.
    J Neuroimmunol; 2011 Feb; 231(1-2):15-22. PubMed ID: 20947176
    [Abstract] [Full Text] [Related]

  • 13. [Multiple sclerosis and pregnancy].
    Ruuskanen J, Malm H, Airas L.
    Duodecim; 2013 Feb; 129(14):1457-64. PubMed ID: 23961604
    [Abstract] [Full Text] [Related]

  • 14. [An update on the treatment options for multiple sclerosis].
    Niino M.
    Brain Nerve; 2012 Dec; 64(12):1421-6. PubMed ID: 23209069
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies.
    Antel JP, Miron VE.
    Clin Neurol Neurosurg; 2008 Nov; 110(9):951-7. PubMed ID: 18502570
    [Abstract] [Full Text] [Related]

  • 16. Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?
    Castrop F, Kowarik MC, Albrecht H, Krause M, Haslinger B, Zimmer C, Berthele A, Hemmer B.
    Neurology; 2012 Mar 20; 78(12):928-30. PubMed ID: 22402856
    [No Abstract] [Full Text] [Related]

  • 17. Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
    Freedman MS.
    Eur J Neurol; 2014 Mar 20; 21(3):377-87, e18-20. PubMed ID: 24237582
    [Abstract] [Full Text] [Related]

  • 18. [New disease-modifying and symptomatic therapies for multiple sclerosis].
    Weise G, Buttmann M.
    MMW Fortschr Med; 2012 Apr 19; 154(7):64-6. PubMed ID: 22558878
    [No Abstract] [Full Text] [Related]

  • 19. Oral therapy for multiple sclerosis--sea change or incremental step?
    Carroll WM.
    N Engl J Med; 2010 Feb 04; 362(5):456-8. PubMed ID: 20089958
    [No Abstract] [Full Text] [Related]

  • 20. New options for early treatment of multiple sclerosis.
    Tintoré M.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.